Bowel cancer care in individuals with an intellectual disability: a population-based cohort study of symptoms, diagnostic pathways, treatment and survival - Report - MDSpire
Advertisement
Bowel cancer care in individuals with an intellectual disability: a population-based cohort study of symptoms, diagnostic pathways, treatment and survival
Management of Bowel Cancer in Patients with Intellectual Disabilities
Overview
This study investigates the risk and management of bowel cancer in individuals with intellectual disabilities (ID), revealing significant disparities in diagnosis, treatment, and survival outcomes. It highlights the need for improved healthcare access and tailored interventions for this vulnerable population.
Background
Intellectual disabilities affect 1%–3% of the global population, leading to unique healthcare challenges and significant health inequalities. Individuals with ID are at a higher risk for bowel cancer, yet they often face barriers in accessing timely screening and treatment, contributing to poorer health outcomes. Addressing these disparities is crucial for improving the quality of care and survival rates in this population.
Data Highlights
No numerical data available in the source material.
Key Findings
Individuals with ID have a higher risk of bowel cancer and related mortality.
Participation in bowel cancer screening is significantly lower among adults with ID (50.3%) compared to the general population (66.8%).
Late-stage diagnoses and emergency presentations are more common in individuals with ID.
Healthcare services often fail to adequately investigate bowel cancer symptoms in patients with ID.
There is a notable reduction in life expectancy for individuals with ID, emphasizing the need for better cancer care.
Clinical Implications
Healthcare providers must recognize the unique challenges faced by patients with intellectual disabilities in the context of bowel cancer. Implementing reasonable adjustments and enhancing communication can improve screening uptake and treatment outcomes for this population.
Conclusion
The findings underscore the urgent need for targeted interventions to address the healthcare disparities experienced by individuals with intellectual disabilities, particularly in the context of bowel cancer management.
by Oliver John Kennedy, Umesh Chauhan, Louise Gorman, Paul Lorigan, Samuel W. D. Merriel, Antonia Perumal, Tjeerd Van Staa, Alison Wright, Darren Mark Ashcroft
Marty Makary’s resignation puts the agency under acting leadership, while BMS and Hengrui unveil a multibillion-dollar pipeline deal and GSK lines up a chronic hepatitis B launch in China.
